Introduction {#S1}
============

Over 1 million skin cancers occur annually in the United States, 80% of which are basal cell carcinomas (BCC) (16% squamous cell carcinomas (SCC), 4% melanomas), making it by far the most common cancer ([@R15]). 1,25 Dihydroxyvitamin D~3~ \[1,25(OH)~2~D~3~\] has been evaluated for its potential anticancer activity ([@R9]), and the accepted basis for the promise of 1,25(OH)~2~D~3~ for the prevention and treatment of malignancy includes its antiproliferative, prodifferentiating effects on many cell types. Epidemiologic evidence supports the importance of adequate vitamin D nutrition for the prevention of a number of cancers including those of the colon and breast ([@R6]; [@R12]; [@R13]; [@R17]; [@R20]).

Recent studies indicate that vitamin D signaling plays a protective role in skin carcinogenesis. Zinser et al. ([@R33]) treated *vitamin D receptor* (*VDR*) null mice (*VDR*KO) bearing medroxyprogesterone pellets with two oral administrations of 7,12 dimethylbenzanthracene (DMBA) at 5.5 and 7 weeks, a protocol designed to induce breast cancers. No breast tumors were observed within 2 months, however during this period, 85% of the *VDR*KO mice developed skin tumors, while no tumors were found in wildtype controls. The tumors were mostly sebaceous, squamous, and follicular papillomas, but several BCC were also observed, while no SCC were reported. These results have recently been confirmed using topical administration of DMBA/TPA, although only papillomas were seen in the *VDR*KO mice, unlike *RXRα*KO, mice which developed both BCC and SCC ([@R18]). The appearance of BCC in these studies is surprising, since the typical malignancy induced in mouse skin by UVR, ionizing radiation, or chemical carcinogens is SCC rather than BCC ([@R7]). The appearance of BCC is characteristic of tumors formed when the hedgehog (Hh) signaling is activated ([@R26]) by mutations in the *Hh* signaling pathway, in particular in *patched1* (*Ptch1*) or over expression of Shh, Gli1 and Gli2 ([@R16]; [@R19]; [@R2]; [@R1]). The predisposition *of VDR*KO mice to skin tumor formation has also been demonstrated using UVB ([@R10]).

Essentially all BCCs, whether arising sporadically or in patients with basal cell nevus syndrome (BCNS) (Gorlin Syndrome), have mutations in *Ptch1*, the membrane receptor for Shh, or other alterations in Hh signaling ([@R16]; [@R2]; [@R1]). This phenotype is also observed in the *Ptch1*+/- (Gorlin) mouse ([@R26]), which, unlike the wild type mouse produces BCC as well as SCC after treatment with UVR or ionizing radiation ([@R26]). In the absence of Shh, Ptch1 inhibits the function of another membrane protein, smoothened (Smoh). Shh reverses this inhibition, freeing Smoh to enable the activation of a family of transcription factors Gli1, Gli2, and Gli3. Gli1 and 2 over-expression in keratinocytes can increase the expression of each other, as well as Ptch1, the anti-apoptotic factor bcl2, cyclins D1 and D2, E2F1, cdc45 (all of which promote proliferation), while suppressing genes associated with keratinocyte differentiation such as *K1, K10, involucrin, loricrin* and the *VDR* ([@R14]; [@R23]; [@R28]; [@R26]; [@R27]). Mice over-expressing Gli1, Gli2, or Shh in their basal keratinocytes ([@R24]; [@R14]; [@R23]) or grafted with human keratinocytes over-expressing Shh ([@R11]) develop BCC like lesions. Furthermore, BCC show over-expression of Ptch1, Smoh, Gli1 and Gli2 ([@R30]; [@R5]). Gli2 may be more critical than Gli1 in mediating Shh activity in that *Gli1* null animals display no obvious phenotype unlike *Gli2* null animals. *Gli2* null mice resemble *Shh* null animals in phenotype, *Gli2* deletion partially rescues *Ptch1* null animals, and Gli2 but not Gli1 is required for Shh signaling in hair follicle development (review in ([@R8])).

Most skin tumors induced by systemic DMBA in mice lacking the *VDR* contain hair follicle elements and/or are of basal cell origin, tumors characteristic of over-expression of the Hh pathway in keratinocytes. The VDR is found in the outer root sheath and basal layer of the interfollicular epidermis, a postulated source for BCC development ([@R4]). Lack of *VDR* causes a marked hyperproliferative response in these cells of the hair follicle and epidermis, with disruption of normal hair follicle cycling and decreased epidermal differentiation ([@R4]; [@R32]). We found that the epidermis and epidermal portion (utricles) of the hair follicles of *VDR*KO animals over-express elements of the Hh signaling pathway (Shh, Ptch1, Smoh, Gli1, and Gli2), suggesting that one of the causes of the increased susceptibility of the epidermis to malignant transformation is due to a loss of 1,25(OH)~2~D~3~ and/or VDR regulation of Hh signaling. When we examined tumors in *VDRKO* mice treated with DMBA or UVB, we found the over expression of the same elements of the Hh signaling pathway predominantly in the tumors compared with adjacent tissue. Using an epidermal explant culture, we found that 1,25(OH)~2~D~3~ represses the expression of at least some members of the *Hh* signaling pathway, suggesting a direct regulation by the *VDR*.

Results {#S2}
=======

Acute UVB exposure increased epidermal thickness and proliferation in *VDR*KO mice {#S3}
----------------------------------------------------------------------------------

To address the short term sensitivity of skin to UVB exposure we irradiated wild-type and *VDR*KO mice with a single dose of UVB (400 mJ/cm2). Wild-type mice displayed increased epidermal thickening 1h and 24h after exposure to UVB with no further increase by 48h ([Fig. 1A](#F1){ref-type="fig"}). This was accompanied with increased PCNA staining, a marker of cellular proliferation, in the epidermis at 1h and 24h with no further increase by 48h ([Fig. 1B](#F1){ref-type="fig"}). *VDR*KO mice displayed a more pronounced epidermal hyperplasia at all time points compared to wild-type mice ([Fig 1A](#F1){ref-type="fig"}), showing an increased and more durable hyperplasia. Consistent with the increased thickening, *VDR*KO mice had increased numbers of PCNA positive cells compared to wild-type mice at 1h and 24h, and these continued to increase at 48h ([Fig. 1B](#F1){ref-type="fig"}).

Over-expression of Hh pathway members in *VDR*KO mice {#S4}
-----------------------------------------------------

To address the long term sensitivity of *VDR*KO mice epidermis to tumor formation, we assessed the protein levels of multiple members of the Hh pathway in *VDR*KO mice and their wild type littermates by immunohistochemistry and western blotting. We examined 11 week old mice, the age matching the appearance of the skin papillomas in *VDR*KO mice treated with DMBA ([@R33]). In wild-type mice Shh, Ptch1 and Smoh were expressed in both hair follicles and inter-follicular epidermis, whereas Gli1 was expressed mostly in hair follicles, and Gli2 expression was not detectable. Expression of all these proteins increased in *VDR*KO mice compared to their wild type littermates ([Fig. 2A](#F2){ref-type="fig"}), and their spatial distribution was also affected by the lack of *VDR*. Shh expression increased in the epidermis of the *VDR*KO mice, but was markedly reduced in the utricles, the remaining portion of the hair follicle structures. Ptch1 was expressed throughout the epidermis and the hair follicle of the wild type mice, but primarily in the utricles and dermal cysts of the *VDR*KO mice. Smoh and Gli1 expression, found primarily in the outer root sheath of the hair follicles of wild-type mice, increased in both hair follicles and inter-follicular epidermis of the *VDR*KO mice. Gli2 expression, not detectable in wild type mice, was strongly expressed in utricles and dermal cysts of *VDR*KO mice. We confirmed quantitatively the increased expression of these proteins using Western blotting. When compared to the house-keeping gene beta-actin, we found an increased expression of Shh (2.02 fold), Ptch1 (1.58 fold), Smoh (3.54 fold), Gli1 (1.17 fold) and Gli2 (1.66 fold) in skin from *VDR*KO mice compared to their wild-type littermates ([Fig. 2B](#F2){ref-type="fig"}).

Different types of skin tumors are induced by UVB in *VDR*KO mice {#S5}
-----------------------------------------------------------------

*VDR*K*O* mice exposed to 40 weeks of UVB irradiation developed an average of 2.7 skin tumors greater than 1 mm in diameter per mouse, with at least 1 tumor per mouse. These tumors included papillomas (78%), BCC (11%), SCC (7.5%), and keratoacanthomas (3.5%). Representative sections of these tumors are presented in [figure 3A](#F3){ref-type="fig"}. Furthermore, after 40 weeks of UVB no tumors were apparent in wild-type and *CYP27B1*KO mice ([Fig. 3B](#F3){ref-type="fig"} and data not shown). No tumors developed in the *VDR*KO mice that were not exposed to DMBA or UVB ([Fig. 3B](#F3){ref-type="fig"} and data not shown).

DMBA and UVB induced skin tumors in *VDR*KO mice express members of the Hh pathway {#S6}
----------------------------------------------------------------------------------

We then examined the expression of Hh signaling pathway members by immunohistochemistry in tumors formed in *VDR*KO mice following DMBA and UVB treatment. In all these tumors we were able to find expression of Shh, Smoh, Ptch1, Gli1 and Gli2 ([Fig. 4A](#F4){ref-type="fig"} and data not shown). Moreover, the expression of these markers was mostly localized to the tumor with little or no expression in adjacent tissues ([Fig. 4A](#F4){ref-type="fig"} and data not shown). We confirmed the expression of these proteins specifically in the DMBA generated skin tumors using Western analysis of protein extracts from these tumors ([Fig. 4B](#F4){ref-type="fig"}). When compared to the house-keeping gene beta-actin, we found an increased expression of Shh (3.08 fold), Ptch1 (1.53 fold), Smoh (3.65 fold), Gli1 (1.75 fold) and Gli2 (1.56 fold) in the tumors compared to tumor-free tissue ([Fig. 4B](#F4){ref-type="fig"}).

1,25(OH)~2~D~3~ repression of the *Hh* pathway in the epidermis {#S7}
---------------------------------------------------------------

To determine whether 1,25(OH)~2~D~3~ directly regulates the expression of components of the *Hh* pathway we measured their expression levels in epidermal explants from wild-type mice, following treatment with 1,25(OH)~2~D~3~ concentrations ranging from 10^-10^M to 10^-7^M. *Shh* was robustly expressed in neonatal epidermal explants but not in proliferating keratinocytes in culture (data not shown). After treatment with 1,25(OH)~2~D~3~, the epidermal explants displayed increased expression of *Cyp24* and decreased expression of *Shh, Gli1, Gli2* and *Ptch1* in a dose dependant manner ([Fig. 5A](#F5){ref-type="fig"}). To verify that 1,25(OH)~2~D~3~ regulation of the expression of those genes was dependent on the *VDR*, we measured their expression levels in epidermal explants from *VDR*KO mice compared to wild-type mice. Treatment with 10^-8^M of 1,25(OH)~2~D~3~ decreased the expression of *Shh* (3.5 fold), *Gli1* (2.4 fold), *Gli2* (2.3 fold) and *Ptch1* (2 fold) in wild-type epidermis. *Smoh* expression was not affected. In contrast, 1,25(OH)~2~D~3~ inhibition of their expression was suppressed in *VDR*KO samples ([Fig. 5B](#F5){ref-type="fig"}). Lack of *VDR* in *VDR*KO samples was verified by the lack of *VDR* expression and the inability of 1,25(OH)~2~D~3~ to induce *Cyp24* expression, compared to wild-type samples (500 fold increase, [Fig. 5B](#F5){ref-type="fig"}). Immunohistochemistry confirmed that Shh is expressed in the most differentiated layer of the epidermis but not in the basal layer of these explants ([Fig. 5C](#F5){ref-type="fig"}).

Discussion {#S8}
==========

Following recent studies showing the sensitivity of *VDR*KO mice to skin tumor formation upon exposure to carcinogen ([@R33]) or to UVB ([@R10]), we investigated potential mechanisms by which *VDR* could act as a tumor suppressor. *VDR*KO mice show increased sensitivity to acute UVB irradiation with respect to epidermal thickening and hyperproliferation. Hyperproliferation being a key element in tumor formation, our data indicate a predisposition of *VDR*KO epidermis to develop skin tumors, although no tumors were found in the *VDR*KO mice not exposed to UVB. Hyper-proliferation was also observed in wild-type, to a lesser extent, but no tumors arise in those mice following 40 weeks of UVB exposure. In a comparable study ([@R10]), wild-type mice developed tumors after 45 weeks of exposure to UVB, with an incidence 85% lower than in *VDR*KO. As a potential mechanism for this hyperproliferative response we found that the epidermal portion (utricles) of the hair follicles and the dermal cysts of *VDR*KO animals over-express elements of the Hh signaling pathway, suggesting that one of the causes of the increased susceptibility of the *VDR*KO epidermis to malignant transformation is due to the loss of 1,25(OH)~2~D~3~ and/or *VDR* regulation of Hh signaling. This potential mechanism is further supported by the expression of elements of the Hh signaling pathway in the tumors arising in *VDR*KO mice treated with DMBA or UVB and the observation that 1,25(OH)~2~D~3~ suppresses the expression of the *Hh* signaling pathway in a *VDR* dependent fashion.

Lack of *VDR* increases the protein expression of the Hh pathway members Shh, Ptch1, Smoh, Gli1 and Gli2 in *VDR*KO mice. Our data show that these proteins are expressed in a spatially controlled way in the wild type animals and in the *VDR*KO even if the levels and areas of expression change. Since one of the main skin defects of the *VDR*KO mice is a blockage of their hair follicle cycling by the end of the first cycle and a progressive hair loss ([@R4]; [@R21]), one might consider that the hair follicle is the main target and regulator of the Hh signaling pathway. When this structure is missing or, as in *VDR*KO mice, altered to become utricles and dermal cysts, the Hh signaling pathway is over expressed in the epidermal and interfollicular epidermal parts of the skin, thus potentially predisposing it to develop tumors. Paradoxically loss of Hh signaling in the cycling portion of the hair follicle may contribute to its failure to cycle, as we recently show that *VDR*KO hair follicles have a decreased expression of Hh signaling and that treatment with an Hh signaling agonist restores partially hair follicle cycling ([@R29]). Moreover, we found that Hh signaling pathway expression is spatially controlled in the epidermis. Shh, for example, is expressed in the most differentiated parts of the epidermis, whereas other members of the pathway have a different distribution, implying a paracrine action for Shh in the epidermis/hair follicle. The separation of the different components of the Hh pathway may explain why keratinocytes in culture express little or no Shh if various feedback/feedforward loops between the different layers of the skin are disrupted in monocultures.

The tumors observed in *VDR*KO mice treated by DMBA or UVB expressed all Hh signaling pathway members analyzed in this study, although as in the normal skin expression of these different pathway members varies in different cells of the tumor, suggesting that the role of the Hh pathway signaling components to the formation of these tumors results from the contribution of different cell types.

Thus we postulate that increased expression of Shh in the keratinocytes of the *VDR*KO mouse activates the Hh signaling pathway, predisposing the skin to the development of tumors in part by stimulating proliferation. Our data using epidermal preparations show that 1,25(OH)~2~D~3~ represses the expression of this pathway in a *VDR* dependent fashion, indicating a direct regulation of the *Hh* pathway by vitamin D. Others have observed that vitamin D may regulate this pathway not only via the genomic actions of 1,25(OH)~2~D~3~ acting through *VDR*, but also by direct inhibition by vitamin D independent of its receptor. The latter possibility stems from recent observations that vitamin D itself as well as its precursor 7-dehydrocholesterol can bind to and inhibit the actions of Smoh, a critical step in Hh signaling ([@R3]). Thus both genomic and nongenomic actions of vitamin D may serve to block tumor formation in the skin.

Our data show that over expression of Hh signaling members in *VDR*KO mice arises when the utricles are well established and the epidermis is clearly hyperproliferative. This suggests that Hh signaling and the loss of the proximal portion of the hair follicle defect might be associated. One explanation might be that the subtle balance of expression of this pathway between the dermal and epidermal parts of the skin is impaired by the lack of *VDR*. Specifically, in *VDR*KO mice the dermal papilla, which plays an important role in hair follicle development and cycling, is dissociated from the hair follicle ([@R4]). Thus, the over-expression of Hh signaling in the epidermis of the *VDR*KO mice may increase sensitivity toward carcinogenesis, whereas at the same time the loss of Hh signaling in the cycling portion of the hair follicle contributes to its failure to cycle. This duality of the role of Hh signaling in the skin between hair follicle and epidermis and its differential regulation by 1,25(OH)~2~D~3~/VDR is reminiscent of an analogous duality with respect to wnt/b-catenin signaling and its regulation by 1,25(OH)~2~D~3~/VDR ([@R25]). Thus, although we have focused on the Hh signaling pathway in this study, these effects of vitamin D signaling on tumor predisposition in the epidermis will no doubt involve a number of pathways involving both the hair follicle and the epidermis that are yet to be fully explored.

Material and Methods {#S9}
====================

Animals {#S10}
-------

All animal experimentation described in the manuscript has been approved by the San Francisco VA *Medical Center Animal Review Committee*.

Mice heterozygous for the *VDR* null mutation, Vdrtm1Ska, bred into the C57BL/6 background, were provided by Dr. Shigeaki Kato (Molecular and Cellular Biosciences, University of Tokyo, Japan). These mice were bred to provide wild type and homozygous mutant *VDR*KO littermates. Genotyping was performed by PCR with different primers designed to amplify the mutant *VDR* DNA and the wild type *VDR* DNA (Table 1a). *VDR*KO DMBA treated mouse samples were provided from experiments described previously ([@R33]).

For UVB exposure, dorsal skin was shaved 24 hours before UVB exposure. Mice (5 weeks old at the start of the study) were irradiated three times per week, with 2--3 days between treatments, and re-shaved as needed. The dorsal skin was exposed to UV irradiation from a band of six FS-40 fluorescent lamps; UVB and UVC wavelengths were filtered out from this UV light using Kodacel cellulose film. The dose of UVB varied to maximize UV exposure with minimal ulceration of the skin, using the following protocol: 120 mJ/cm^2^ for 2 weeks, the dose was then increased 25% per week for 5 weeks, up to 400 mJ/cm^2^ for 9 weeks, followed by 200 mJ/cm^2^ until week 40 ([@R10]). Skin tumors were characterized with the help of the dermato-pathology department of the San Francisco VA medical center.

Immunohistochemistry {#S11}
--------------------

Affinity-purified antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) found to recognize mouse proteins following heat-induced antigen retrieval treatment (in 10 mM citrate buffer; pH 6.0, at 95°C, for 30 min) were used. The primary antibodies were used at a concentration of 4 ug per ml in 10 mM Tris buffer, pH 7.6, containing 4% bovine serum albumin, 1% teleostean skin gelatin, 0.1% Tween 20, and 500 mM NaCl. The binding of the primary antibody to the sections was detected by affinity-purified, biotinylated goat anti-rabbit IgG, followed by ABC-peroxidase reagent, both purchased from Vector (Burlingame, CA). Peroxidase activity was detected with diaminobenzidine substrate (QualTek Laboratories, Santa Barbara, CA) followed by counterstaining with methyl green or hematoxylin. Omitting the first antibody resulted in no signal, indicating the specificity of the immunodetection.

Protein extraction and Western Blot {#S12}
-----------------------------------

Proteins were extracted from the back skin of mice or from the DMBA treated tumors after homogenization with a Polytron in RIPA buffer (150mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS, 50mM Tris). Protein concentrations were determined by the BCA Protein Assay Kit (Pierce Corp., Rockford, IL). Equal amounts of protein samples were electrophoresed through 4--15% gradient polyacrylamide gels and electroblotted onto polyvinylidene fluoride membranes (Immobilon-P, 0.45 mm; Millipore Corp., Bedford, MA). After incubation in blocking buffer (PBS, 5% nonfat milk, and 0.5% Tween 20), the blot was incubated overnight at 4°C with appropriate primary antibodies: polyclonal antibody against mouse Gli1 (Abcam, Cambridge, MA) at a dilution of 1:1000, Gli2, Patched, Shh or Smoh (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at a dilution of 1:200. After washing 3 times with the blocking buffer, the membranes were incubated for 1 h with the appropriate anti-IgG secondary antibody conjugated to horseradish peroxidase (Amersham Biosciences) in the blocking buffer. After a second series of washes, bound antibody complexes were visualized using the SuperSignal ULTRA chemiluminescent kit (Pierce) and subsequent exposure to X-ray film. X-ray films were then scanned and the intensity of each band was quantified using Kodak 1D™ 3.6.4 (Kodak, Rochester, NY). The data presented are representative of three independent experiments.

Skin separation and cell culture {#S13}
--------------------------------

Skin separation was performed as described by Lichti et al ([@R22]). Briefly, back skin from neonatal mice was collected and separated overnight in HBSS with 5U/ml dispase. Epidermal sheets (epidermal explants) were then peeled from the dermal fraction and maintained in culture in 154CF medium (Cascade Biologics, Portland, OR) with 1.2 mM CaCl~2~ and 10% chelexed fetal bovine serum. Epidermal explants were treated for 24h with 1,25(OH)~2~D~3~ (10^-10^ to 10^-7^M) or vehicle (100% Ethanol).

Quantitative real time PCR {#S14}
--------------------------

Total RNA from back skin of mice, separated epidermis and dermis or cell culture was extracted using RNA-STAT 60 (Tel-Test, Inc., Friendwood, TX). Concentration and purity were determined by measuring the absorbance at OD 260/280 nm. 1ug of RNA was reversed transcribed using random hexamers with the TaqMan reverse transcription kit (Applied Biosystems, Foster City, CA). The amount of cDNA was then quantified by quantitative real time PCR, performed on a PE Biosystems model 7900 HT sequence detector. The PCR amplification was done using TaqMan Universal PCR Master Mix (Applied Biosystems) and TaqMan Gene Expression Assays (Applied Biosystems) using their proprietary primer/probe sets or SYBRGreen Universal PCR Master Mix (Applied Biosystems) and primers from PrimerBank ([@R31]). *Mitochondrial ribosomal protein L19* (*Mrpl19*) was used as the control gene to which the results were normalized.
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![Increased hyperplasia and hyperproliferation in UVB exposed epidermis from *VDR*KO mice\
Wild-type mice exposed to 1 dose of UVB (477 mJ/cm2) show epidermal hyperplasia (**A**, H&E staining) and increased proliferation (**B**, PCNA staining), 1h and 24h after treatment with no further increase at 48h. *VDR*KO mice exposed to the same dose of UVB show significantly more pronounced epidermal hyperplasia (**A**) at 1h and 24h that continued to increase at 48h. *VDR*KO epidermis also show increased proliferation (**B**) comparable to that of wild-type mice at 1h and 24h that continued to increase at 48h. The bars denote 50 μm.](nihms301491f1){#F1}

![Increased protein levels of Hh signaling pathway members in *VDR*KO mice\
**A**. Shh, Ptch1, Smoh, Gli1 and Gli2 proteins as shown by the brown signal were detected in the epidermis and hair follicles from *VDR*KO mice and their wild-type littermates at 11 weeks after birth by immunocytochemistry. Slides were counterstained with hematoxylin (blue stain). The bar denotes 50 μm. **B**. Shh, Ptch1, Smoh, Gli1 and Gli2 protein levels were quantified by western blot in skin from *VDR*KO mice and their wild-type littermates and compared to beta-actin as a control. The numerical value represents the average ratio of *VDR*KO band intensity versus wild-type band intensity after subtraction of background level from three independent experiments. \* p\<0.05.](nihms301491f2){#F2}

![Skin structures induced by UVB in *VDR*KO mice\
**A**. Representative structures from mice exposed to 40 weeks of UVB irradiation were collected and classified into papillomas, squamous cell carcinomas (SCC), keratoacanthomas and basal cell carcinomas (BCC). **B**. Representative structure of 8 months old *VDR*KO skin without UVB exposure and wild-type mice after 40 weeks of UVB exposure. The bars denote 50 μm.](nihms301491f3){#F3}

![Expression of members of the Hh signaling pathway in the tumors from *VDR*KO mice\
**A**. Shh, Ptch1, Smoh, Gli1 and Gli2 proteins as shown by the brown signal were detected by immunohistochemistry in a papilloma from a *VDR*KO mouse treated with DMBA and in a BCC from a *VDR*KO mouse treated with UVB. Slides were counterstained with hematoxylin (blue stain). The bars denote 50 mm. **B**. Shh, Ptch1, Smoh, Gli1 and Gli2 protein levels were measured by western blot in skin tumors and tumor free tissue from DMBA treated *VDR*KO mice. The numerical value represents the mean ratio of the tumor band intensity versus tumor free tissue band intensity after subtraction of background level from three independent experiments. \* p\<0.05.](nihms301491f4){#F4}

![1,25(OH)~2~D~3~, through *VDR* action, represses *Hh* pathway expression in the epidermis\
**A**. 1,25(OH)~2~D~3~ treatment of epidermal preparations from wild-type mice in culture for 24h induced *Cyp24* expression and repressed *Shh, Gli1, Gli2* and *Ptch1* expression in a dose dependant manner. **B**. Epidermal preparations from wild-type and *VDR*KO mice in culture were treated with 1,25(OH)~2~D~3~ 10^-8^M or EtOH for 24h. Absence of *VDR* expression was verified in *VDR*KO mice and their epidermis failed to respond to 1,25(OH)~2~D~3~ induction of *Cyp24* expression unlike that in wild-type mice. 1,25(OH)~2~D~3~ treatment repressed *Shh, Gli1, Gli2* and *Ptch1* expression only in wild-type preparations. \* p\<0.05 **C**. Shh protein expression was localized in the upper layers of the epidermis by immunohistochemistry on a full skin section. The bar denotes 50 μm.](nihms301491f5){#F5}
